Journal of Molecular and Cellular Cardiology
Volume 42, Issue 2 , Pages 295-303, February 2007

Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment

Research Center of Medical Sciences, Guangdong Provincial People’s Hospital, Guangdong Provincial Cardiovascular Institute, 96 Dongchuan Road, Image Bldg., Guangzhou 510080, P.R. China

Received 16 May 2006; received in revised form 24 June 2006; accepted 5 July 2006.

Abstract 

Heart attacks and congestive heart failure remain among the world's most prominent health challenges despite the many breakthroughs. Bone marrow mesenchymal stem cells (BMSCs) have the potential to transdifferentiate into myocytes if an appropriate cardiac environment is provided. This study is meant to investigate the ability of BMSCs to differentiate into cardiomyocytes in a conditioned medium. BMSCs were isolated from rat femurs and tibias using Percoll gradient centrifugation method. Cells were expanded as undifferentiated cells in culture for more than 3 passages and their phenotypes were identified with flow cytometer. BMSCs were cocultured with neonatal rat ventricular myocytes in a rate of 1:10 separated by semipermeable membrane. BMSCs marker of CD29 were highly expressed (98.89±1.2%); however, CD34 could hardly be identified (5.61±0.1%). After coculturing with myocytes, some of BMSCs showed contraction which became more regular and more vigorous. As assessed by RT-PCR, SERCA2 and RyR2 were expressed by newly formed cells from 1 to 3 weeks. Immunostaining of newly differentiated BMSCs revealed positivity for cTnT. Some of these cells were positive for sarcomeric α-actinin, desmin, cTnT, and cTnI. Western blotting showed that cTnI protein expression was upregulated in these cells from 1 to 3 weeks. Newly formed BMSCs exhibited ultrastructural features of sarcomere formation and inward rectifier potassium current (IK1). It is concluded that BMSCs possess the potential to differentiate into cardiomyocytes in the cardiac environment. BMSCs provide an excellent model for development of stem cell therapeutics, and their potential in the cardiac repair under various pathological conditions.

Abbreviations: BMSCs, bone marrow mesenchymal stem cells, AMI, acute myocardial infarction, BMP-2, bone morphogenetic protein-2, FGF-4, fibroblast growth factor-4, MCs, myocardial cells, CLCs, cardiomyocyte-like cells, FITC, fluorescein isothiocyanate, TEM, transmission electron microscopy, cTn, cardiac troponin, vWF, von Willebrand factor, PMSF, phenylmethyl sulfonylfluoride, SERCA, sarco-endoplasmic reticulum Ca2+, RyRs, ryanodine receptor channels

Keywords: Bone marrow stem cells, Differentiation, Cardiomyocytes, Coculture, Physical contact

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-2828(06)00714-0

doi:10.1016/j.yjmcc.2006.07.002

Journal of Molecular and Cellular Cardiology
Volume 42, Issue 2 , Pages 295-303, February 2007